Patient Perspectives: Propranolol for infantile hemangiomas.
D000284:Administration, Oral; D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D017028:Caregivers / Q000193:education; D000066491:Clinical Decision-Making; D005260:Female; D018324:Hemangioma, Capillary / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D010290:Parents / Q000193:education; D010358:Patient Participation; D011433:Propranolol / Q000009:adverse effects / Q000627:therapeutic use*; D012075:Remission, Spontaneous; D018570:Risk Assessment; D012878:Skin Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists; D011433:Propranolol